Global Veterinary Orthopedic Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Veterinary Orthopedic Medicine Market is presumed to reach the market size of nearly USD 7.79 BN by 2030 from USD 3.88 BN in 2022 with a CAGR of 9.11% under the study period 2023 - 2030.

Veterinary orthopedic medicine refers to the specialized veterinary medicine that focuses on the diagnosis, treatment, and prevention of musculoskeletal conditions and injuries in animals. This branch of veterinary medicine addresses issues related to bones, joints, ligaments, tendons, and muscles in various animal species.

MARKET DYNAMICS

The Veterinary orthopedic medicine market is experiencing growth driven by several key factors. Increased awareness and concern for the well-being of companion animals contribute to a rising demand for specialized veterinary orthopedic care as pet owners seek advanced treatments for musculoskeletal conditions. The prevalence of orthopedic issues in animals, including osteoarthritis and cruciate ligament injuries, is on the rise, fueled by factors like aging animal populations and increased engagement in activities. Advancements in veterinary medical technology and surgical techniques play a pivotal role, with innovations in orthopedic implants and minimally invasive procedures enhancing treatment outcomes. Collaborations within the veterinary community and with research institutions contribute to knowledge exchange and the development of new treatment modalities. The growing pet insurance industry further impacts the market, facilitating access to advanced orthopedic treatments for pet owners.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary orthopedic medicine. The growth and trends of veterinary orthopedic medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the veterinary orthopedic medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Biologics (Stem Cells, Platelet-Rich Plasma (Prp), Monoclonal Antibody)
Viscosupplements
Pharmaceuticals (Steroids, Nsaids, Others)

By Animal

Canine
Feline
Equine
Cattle
Swine
Others

By Application

Osteoarthritis
Degenerative Joint Disease
Joint Inflammation/Pain
Other

By Route Of Administration

Oral
Parenteral (Intra-Muscular, Intra-Articular, Others)
Topical

By End-Use

Veterinary Hospitals
Veterinary Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Orthopedic Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Orthopedic Medicine market include Zoetis, Inc., Boehringer Ingelheim, Elanco Animal Health, American Regent, Inc., Merck Animal Health (Merck & Co. Inc), Vetoquinol S.A., Ceva Sante Animale, Virbac, Biogenesis Bago, Ardent Animal Health, LLC, Bioiberica S.A.U, PetVivo Holdings, Inc. (Spryng), Contipro A.S., VetStem, Inc., Enso Discoveries, Contura Vet US, T-Cyte Therepeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113276

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . VETERINARY ORTHOPEDIC MEDICINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Animal
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Route of Administration
- 3.7.5 Market Attractiveness Analysis By End-use
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody) Historic and Forecast Sales by Regions
5.5 Viscosupplements Historic and Forecast Sales by Regions
5.6 Pharmaceuticals (Steroids, NSAIDS, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ANIMAL

6.1 Overview by Animal
6.2 Historical and Forecast Data
6.3 Analysis by Animal
6.4 Canine Historic and Forecast Sales by Regions
6.5 Feline Historic and Forecast Sales by Regions
6.6 Equine Historic and Forecast Sales by Regions
6.7 Cattle Historic and Forecast Sales by Regions
6.8 Swine Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Osteoarthritis Historic and Forecast Sales by Regions
7.5 Degenerative Joint Disease Historic and Forecast Sales by Regions
7.6 Joint Inflammation/Pain Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

8.1 Overview by Route of Administration
8.2 Historical and Forecast Data
8.3 Analysis by Route of Administration
8.4 Oral Historic and Forecast Sales by Regions
8.5 Parenteral (Intra-muscular, Intra-articular, Others) Historic and Forecast Sales by Regions
8.6 Topical Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY END-USE

9.1 Overview by End-use
9.2 Historical and Forecast Data
9.3 Analysis by End-use
9.4 Veterinary Hospitals Historic and Forecast Sales by Regions
9.5 Veterinary Clinics Historic and Forecast Sales by Regions
9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. South East Asia Sales Analysis
- 10.5.10. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE VETERINARY ORTHOPEDIC MEDICINE COMPANIES

11.1. Veterinary Orthopedic Medicine Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF VETERINARY ORTHOPEDIC MEDICINE INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Zoetis Inc.
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Boehringer Ingelheim
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Elanco Animal Health
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. American Regent Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Merck Animal Health (Merck & Co. Inc)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Vetoquinol S.A.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Ceva Sante Animale
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Virbac
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Biogenesis Bago
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Ardent Animal Health LLC
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Bioiberica S.A.U
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. PetVivo Holdings Inc. (Spryng)
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. Contipro A.S.
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. VetStem Inc.
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Enso Discoveries
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Contura Vet US
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. T-Cyte Therepeutics
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies